Predilife SA

As of December 31, 2024, Predilife SA carries a market capitalization of 13.49M, placing it among publicly traded companies globally. Its enterprise value stands at 17.38M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Predilife SA's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2024, Predilife SA has 3.75M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Predilife SA maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Predilife SA's stock has declined approximately 67.83% over the past 52 weeks. The 50-day moving average sits at 1.10, while the 200-day moving average is 2.53.

As of December 31, 2024, Predilife SA holds 1.06M in cash and equivalents against 4.95M in total debt, resulting in a net debt position of 3.89M. Total book value stands at -4.27M, with working capital of 291,838.00 providing operational flexibility.